MediciNova secures new U.S. patent for MN-166 in ophthalmic disease; shares up 9%

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

MediciNova secures new U.S. patent for MN-166 in ophthalmic disease; shares up 9%

To read the full story on Seeking Alpha, click here.

Medicinova (NASDAQ:MNOV)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Medicinova Charts.

Medicinova (NASDAQ:MNOV)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Medicinova Charts.

Medicinova Inc News

MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO)
Tuesday 2 April 2024 (1 month ago) • GlobeNewswire Inc.

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan
Tuesday 26 March 2024 (1 month ago) • GlobeNewswire Inc.

MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society
Wednesday 20 March 2024 (1 month ago) • GlobeNewswire Inc.

MediciNova Announces New Data and Results of MN-166 (ibudilast) in Chlorine Gas-induced Acute Lung Injury Presented at the 63rd Annual Meeting of the Society of Toxicology
Tuesday 12 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Friday 19 January 2024 (3 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Friday 19 January 2024 (3 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Friday 19 January 2024 (3 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Friday 19 January 2024 (3 months ago) • Edgar (US Regulatory)

MediciNova Receives a Notice of Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in China
Wednesday 17 January 2024 (4 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 11 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 11 January 2024 (4 months ago) • Edgar (US Regulatory)

More Medicinova Inc News Articles

Alternet Systems (PK)

Marketing Worldwide (PK)

Bell Buckle (PK)

Ubiquitech Software (PK)

Yuenglings Ice Cream (PK)

Umbra Applied Technologies (PK)

Moon Equity (PK)

Auto Parts 4Less (PK)

AMC Entertainment

Brookmount Explorations (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions